Contact
News - Cellvizio - Oct 19, 2016

Cellvizio®’s strong clinical efficacy in the prevention of certain pancreatic cancers confirmed by positive results from CONTACT study presented at UEGW 2016

Click to read more

You might also like to read

MKT Card.png
NEWS - Cellvizio

Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022

Discover
MKT Card.png
NEWS - Cellvizio

Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery

Discover
News & Events Card Image (2).png
NEWS - Cellvizio

Download the Cellvizio App, now available on iPhone and Android

Discover